arrow
Back
J

Jonathan W. Friedberg

University of Rochester

80H-index
726Paper Count
3.0WCitation Count
Published Papers 111
Publication Date
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826)
err2026-07-31
err0
errOAAI
errSairah Ahmed; Hongli Li; Alex F. Herrera; Anamarija M. Perry; Alexandra E. Kovach; Sarah C. Rutherford; Kelly Davison; Sharon M. Castellino; Andrew M. Evens; Brad Kahl; Nancy L. Bartlett; John P. Leonard; Margaret A. Shipp; Sonali M. Smith; Kara M. Kelly; Michael LeBlanc; Jonathan W. Friedberg; Joo Y. Song
errShare
errSave
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy
errBlood
IF23.1
err2026-04-16
err0
PREAI
errProkop Vodička; Tarec Christoffer El-Galaly; Vít Procházka; Christopher R Flowers; Diego Villa; Caroline E Dietrich; Lasse H Jakobsen; Hervé Ghesquières; Michael R Clausen; Robert Kridel; Chan Y Cheah; Eliza A Hawkes; Björn Wahlin; Maher K Gandhi; Melissa C Larson; Elliot J Cahn; Jonathan W Friedberg; Peter Martin; Dai Chihara; Jonathon B Cohen
errShare
errSave
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
err2026-01-28
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial
err2025-12-01
err0
errOAAI
errDanilov, Alexey, V; Li, Hongli; Shadman, Mazyar; Rimsza, Lisa; Zebari, Ahmad; Smith, Sonali M.; LeBlanc, Michael; Friedberg, Jonathan W.; Carlson, Christopher; Song, Joo Y.
errShare
errSave
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
err2025-11-01
err0
PREAI
errToumeh, Nadia; Larson, Melissa; Negaard, Brianna; Casulo, Carla; Ahmed, Sairah; Maurer, Matthew; Feldman, Andrew; Mou, Eric; Cohen, Jonathon; Habermann, Thomas; Chihara, Dai; Lossos, Izidore S.; Friedberg, Jonathan; Kahl, Brad; Martin, Peter; Flowers, Christopher R.; Cerhan, James R.; Williams, Annalynn M.; Rosenthal, Allison; Ainsworth, Ali; Thompson, Carrie; Durani, Urshila
errShare
errSave
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
err2025-10-16
err0
errOAAI
errSimonetta Viviani; Chiara Pavoni; Sally F. Barrington; Luca Guerra; Heiko Schöder; Peter Johnson; Amy A. Kirkwood; Deborah M. Stephens; Jonathan W. Friedberg; Stephane Chauvie; Michael V. Knopp; Stefano Luminari; Daniel Molin; Paolo Corradini; Andrea Gallamini; Alessandro Rambaldi; Corrado Tarella
errShare
errSave
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
err2025-10-07
err0
PREAI
errJames R. Cerhan; Tereza Sokolova; Elliott J. Cahn; Mazie Tsang; Christopher S. Strouse; Michelle A. T. Hildebrandt; Allison C. Rosenthal; Andrew L. Feldman; David L. Jaye; Peter Martin; Jonathon B. Cohen; Brad S. Kahl; Izidore S. Lossos; Jonathan W. Friedberg; Loretta J. Nastoupil; Brian K. Link; Thomas M. Habermann; Matthew J. Maurer; Carla Casulo; Carrie A. Thompson; Annalynn M. Williams; Christopher R. Flowers
errShare
errSave
PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study
errBlood
IF23.1
err2025-09-29
err0
errOAAI
errCarrie Thompson; Marek Trněný; Franck Morschhauser; Gilles Salles; Patrick M. Reagan; Mark Hertzberg; Huilai Zhang; Catherine Thieblemont; Bei Hu; Gustavo Fonseca; Won Seog Kim; Maurizio Martelli; Amitkumar Mehta; Avrita Singh; Mark Yan; Jamie Hirata; Matthew Sugidono; Calvin Lee; Jeff P. Sharman; Neha Mehta-Shah; Christopher R. Flowers; Hervé Tilly; Neil Chua; René-Olivier Casasnovas; Fiona Miall; Tae Min Kim; Xavier Cheng-Hong Tsai; Sunita Nasta; Seung Tae Lee; Jonathan W. Friedberg
errShare
errSave
Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma
err2025-09-22
err0
errOAAI
errColleen A. Ramsower; George Wright; Hongli Li; James R. Cerhan; Matthew J. Maurer; Raphael Mwangi; Allison C. Rosenthal; Anne J. Novak; Brian K. Link; Thomas E. Witzig; Thomas M. Habermann; Robert Kridel; Michael R. LeBlanc; Mazyar Shadman; Sonali M. Smith; Jonathan W. Friedberg; David W. Scott; Christian Steidl; Louis M. Staudt; Lisa M. Rimsza
errShare
errSave
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study
err2025-09-01
err0
PREAI
errMariano, John; Strawderman, Myla; Snyder, Eric; Faugh, Tina; Wallace, Danielle S.; Zent, Clive S.; Barr, Paul; Reagan, Patrick M.; Friedberg, Jonathan W.; Casulo, Carla
errShare
errSave
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
err2025-08-01
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Vitamin D in patients with low tumor-burden indolent non- Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
err2024-12-01
err1
errOAAI
errFriedberg, Jonathan W.; Brady, Michael T.; Strawderman, Myla; Kahl, Brad S.; Lossos, Izidore S.; Cohen, Jonathon B.; Reagan, Patrick M.; Casulo, Carla; Averill, Barbara L.; Baran, Andrea; Sutamtewagul, Grerk; Barr, Paul M.; Leonard, John P.; Ashton, John M.; Strang, John G.; Vega, Francisco; Peterson, Derick R.; Nastoupil, Loretta J.
errShare
errSave
Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial
errBLOOD
IF23.1
err2024-11-25
err2
PREAI
errFenske, Timothy S.; Wang, Xin Victoria; Till, Brian G.; Blum, Kristie A.; Lunning, Matthew; Lazarus, Hillard M.; Fishkin, Paul A. S.; Shields, Lale Kostakoglu; Scott, David W.; Lacasce, Ann S.; Johnston, Patrick B.; Cashen, Amanda F.; Popplewell, Leslie L.; Dean, Robert M.; Ahmed, Nausheen; Shah, Nirav N.; Wagner-Johnston, Nina D.; Hu, Boyu; Dholaria, Bhagirathbhai R.; Little, Richard F.; Friedberg, Jonathan W.; Leonard, John P.; Kahl, Brad S.
errShare
errSave
Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errWagner-Johnston, Nina; Jegede, Opeyemi; Spurgeon, Stephen E.; Maddocks, Kami J.; Yang, David T.; Romanoff, Justin; Paludo, Jonas; Caimi, Paolo F.; Bartlett, Nancy L.; Reagan, Patrick M.; Sawalha, Yazeed; Hoffmann, Marc; Hu, Boyu; Aziz, Ashraf R.; Marques, Helga; Shields, Lale Kosakoglu; Leonard, John P.; Friedberg, Jonathan W.; Kahl, Brad S.
errShare
errSave
EO2463 Peptide Immunotherapy in Patients with Newly Diagnosed Asymptomatic Follicular Lymphoma Results in Monotherapy Objective Clinical Responses Linked with Anti-Peptide Specific CD8 Memory T Cell Responses: The EONHL1-20/Sidney Study
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBisneto, Jose C. Villasboas; Smith, Stephen D.; Wallace, Danielle S.; Marolleau, Jean Pierre; Garcia, Carlos Grande; Merryman, Reid W.; Bosch, Francesc; Arcaini, Luca; Pinto, Antonio; Gutierrez, Norma C.; Till, Brian G.; Morel, Pierre; Mora, Rocio Figueroa; Garcia, Cristina; Rattotti, Sara; Aubergeon, Lucie; Chene, Laurent; Fagerberg, Jan; Zinzani, Pier Luigi; Armand, Philippe; Friedberg, Jonathan W.; Ansell, Stephen M.
errShare
errSave
Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errAlencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.
errShare
errSave
Understanding the Patient Perspective on Treatment Preferences for Follicular Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errTsang, Mazie; Durani, Urshila; Day, Jonathan R.; Larson, Melissa C.; Holets, Matthew; Yost, Kathleen J.; Cohen, Jonathon B.; Friedberg, Jonathan W.; Lossos, Izidore S.; Martin, Peter; Kahl, Brad S.; Habermann, Thomas M.; Nastoupil, Loretta; Cerhan, James R.; Flowers, Christopher R.; Link, Brian K.; Casulo, Carla; Maurer, Matthew J.
errShare
errSave
Trial in Progress- Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBeaven, Anne W.; Geyer, Susan M.; Cohen, Jonathon B.; Phillips, Tycel; Dockter, Travis; Pophali, Priyanka A.; Thanarajasingam, Gita; Mazza, Gina L.; Alencar, Alvaro J.; Dinner, Shira N.; Hsi, Eric D.; Welliver, Meng; Nikcevich, Daniel; Kahl, Brad S.; Friedberg, Jonathan W.; Bartlett, Nancy L.; Leonard, John P.
errShare
errSave
Nivolumab plus AVD in Advanced-Stage Classic Hodgkin's Lymphoma
err2024-10-17
err2
PREAI
errHerrera, A. F.; LeBlanc, M.; Castellino, S. M.; Li, H.; Rutherford, S. C.; Evens, A. M.; Davison, K.; Punnett, A.; Parsons, S. K.; Ahmed, S.; Casulo, C.; Bartlett, N. L.; Tuscano, J. M.; Mei, M. G.; Hess, B. T.; Jacobs, R.; Saeed, H.; Torka, P.; Hu, B.; Moskowitz, C.; Kaur, S.; Goyal, G.; Forlenza, C.; Doan, A.; Lamble, A.; Kumar, P.; Chowdhury, S.; Brinker, B.; Sharma, N.; Singh, A.; Blum, K. A.; Perry, A. M.; Kovach, A.; Hodgson, D.; Constine, L. S.; Shields, L. K.; Prica, A.; Dillon, H.; Little, R. F.; Shipp, M. A.; Crump, M.; Kahl, B.; Leonard, J. P.; Smith, S. M.; Song, J. Y.; Kelly, K. M.; Friedberg, J. W.
errShare
errSave
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101
err2024-06-14
err2
errOAAI
errBatchelor, Tracy T.; Giri, Sharmila; Ruppert, Amy S.; Geyer, Susan M.; Smith, Scott E.; Mohile, Nimish; Swinnen, Lode J.; Friedberg, Jonathan W.; Kahl, Brad S.; Bartlett, Nancy L.; Hsi, Eric D.; Cheson, Bruce D.; Wagner-Johnston, Nina; Nayak, Lakshmi; Leonard, John P.; Rubenstein, James L.
errShare
errSave